Market capitalization | $495.64m |
Enterprise Value | $469.38m |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 12.92 |
P/S ratio (TTM) P/S ratio | 13.64 |
Dividend yield | 6.18% |
Last dividend (FY25) | $2.38 |
Revenue growth (TTM) Revenue growth | 4.11% |
Revenue (TTM) Revenue | $36.33m |
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
Dec '24 |
+/-
%
|
||
Revenue | 36 36 |
4%
4%
|
|
Gross Profit | 30 30 |
4%
4%
|
|
EBITDA | 24 24 |
17%
17%
|
EBIT (Operating Income) EBIT | 24 24 |
17%
17%
|
Net Profit | 23 23 |
17%
17%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
BlackRock Health Sciences Trust is a closed-end investment fund. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The company was founded on March 31, 2005 and is headquartered in Wilmington, DE.
Head office | United States |
CEO | John Perlowski |
Founded | 2005 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.